Iga Swiatek Accepts One-Month Ban Following Doping Controversy.
World number two and five-time Grand Slam champion Iga Swiatek has accepted a one-month suspension after testing positive for the banned substance trimetazidine (TMZ).
The 23-year-old reigning French Open champion’s positive test stemmed from an out-of-competition sample in August 2024, during her reign as world number one. The International Tennis Integrity Agency (ITIA) determined that the banned substance was inadvertently ingested due to contamination in a regulated melatonin supplement Swiatek had been taking to manage jet lag and sleep issues.
The ITIA concluded that Swiatek’s fault was minimal, placing her case in the lowest category for ‘No Significant Fault or Negligence.’
Reflecting on the ordeal, Swiatek expressed her relief and determination to move forward. “In the last two-and-a-half months, I was subject to strict ITIA proceedings, which confirmed my innocence,” she stated on Instagram. “The only positive doping test in my career, showing unbelievably low levels of a banned substance I’ve never heard about before, put everything I’ve worked so hard for my entire life into question.”
She continued: “Both me and my team had to deal with tremendous stress and anxiety. Now everything has been carefully explained, and with a clean slate, I can go back to what I love most.”
Swiatek’s provisional suspension, effective from 12 September, saw her miss three tournaments before successfully appealing. Her ability to return to competition highlights the integrity of her case and her commitment to maintaining a clean and honest sporting career.
Having won the French Open in four of the past five seasons, Swiatek’s focus now shifts back to competing at the highest level. Her resilience through this challenging period further underscores her status as one of tennis’s most formidable athletes.
